Series B - Nabriva Therapeutics - Apr 7, 2015 Funding Round Profile - Cointime

Bitcoin $78,762.17 +2.92%
Ethereum $3,171.21 +4.24%
BNB $631.46 +0.35%
Optimism $1.66 +1.06%
Arbitrum $0.62 +2.59%
Solana $205.68 +2.40%
Polygon $0.40 +3.46%
Cosmos $4.95 +4.35%
Avalanche $31.45 +7.16%

Bitcoin $78,762.17 +2.92%
Ethereum $3,171.21 +4.24%
BNB $631.46 +0.35%
Optimism $1.66 +1.06%
Arbitrum $0.62 +2.59%
Solana $205.68 +2.40%
Polygon $0.40 +3.46%
Cosmos $4.95 +4.35%
Avalanche $31.45 +7.16%

Nabriva Therapeutics

company

Funding Round

Series B

Money Raised

$ 120M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
GLS Ventures	-	-	-	Detail
Phase4 Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 28, 2009	Series Unknown	€ 15M	GLS Ventures,Phase4 Partners	Detail
Sep 4, 2007	Series Unknown	$ 56M	Phase4 Ventures	Detail